LY 178002
Names
Biological Activity
[Description]:
LY 178002 is a potent inhibitor of 5-lipoxygenase, phospholipase A2, with IC50 of 0.6 μM for 5-1ipoxygenase, inhibits cellular production of LTB4 by human polymorphonuclear leukocytes, and shows relatively weak inhibition on cyclooxygenase.
[Related Catalog]:
[Target]
5-Lipoxygenase (5-LPO):0.6 μM (IC50)
PLA2:6.3 μM (IC50)
FCO:4.2 μM (IC50)
Cyclooxygenase
[In Vitro]
LY178002 inhibits the generation of LTB4, PLA2 and FCO with IC50s of 0.1, 6.3 and 4.2 μM [1].
[In Vivo]
LY 178002 (50 mg/kg) inhibits soft tissue swelling in the uninjected paw by 81%, and inhibits bone damage in rats. The minimum effective dose for LY178002 is 10 mg/kg p.o. In the established FCA model LY178002 at 50 mg/kg p.o. inhibits the uninjected paw swelling by 75%[1].
[References]
[Related Small Molecules]
U73122
|
4-Acetamidophenol
|
Aspirin
|
Zileuton
|
D609
|
Paradol
|
Ginsenoside Rg3
|
Ginsenoside Compound K
|
Xanthohumol
|
Ibuprofen
|
Darapladib
|
Diclofenac
|
ML355
|
NS-398
|
Meloxicam
Chemical & Physical Properties
[ Density]:
1.139g/cm3
[ Boiling Point ]:
489.9ºC at 760 mmHg
[ Molecular Formula ]:
C18H25NO2S
[ Molecular Weight ]:
319.46200
[ Flash Point ]:
250.1ºC
[ Exact Mass ]:
319.16100
[ PSA ]:
78.12000
[ LogP ]:
4.42450
[ Vapour Pressure ]:
3.2E-10mmHg at 25°C
[ Index of Refraction ]:
1.591
[ Storage condition ]:
2-8℃